Trial Summary
What is the purpose of this trial?
The goal of this study is to test the efficacy of anesthesia-induced dreaming for PTSD in a double-blind, randomized controlled trial in a non-surgical setting (Phase II). The investigators predict that inducing and sustaining a dream state prior to emergence from anesthesia will result in reduced symptoms of PTSD. Half of the participants will be randomly allocated to a Dream Group, while the other half will be in the No-Dream group.
Research Team
BD
Boris D Heifets, MD, PhD
Principal Investigator
Stanford University
Eligibility Criteria
This trial is for individuals with Post-Traumatic Stress Disorder (PTSD). Participants should be healthy enough to undergo anesthesia. Specific details about inclusion and exclusion criteria are not provided, but typically these would outline who can or cannot participate based on health conditions, medications, or other factors.Inclusion Criteria
I have been diagnosed with PTSD by a professional.
Body mass index between 17-32 kg/m2
I am not able to have children or I am using reliable birth control.
See 4 more
Exclusion Criteria
Total CAPS-5 score ≤20 at screening
Current diagnosis of Axis I disorders other than specified, unless comorbid and clinically unstable, and/or the focus of treatment for the past six months or more
History of anorexia nervosa, bulimia nervosa, or eating disorder within five years of screening
See 15 more
Treatment Details
Interventions
- Propofol anesthesia (Behavioural Intervention)
Trial OverviewThe study is testing if using Propofol anesthesia to induce dreams can help reduce PTSD symptoms. It's a Phase II trial where participants are split into two groups: one experiences induced dreaming ('Dream Group'), while the other does not ('No-Dream group'). The allocation is random and both participants and researchers do not know who is in which group (double-blind).
Participant Groups
2Treatment groups
Active Control
Placebo Group
Group I: Dream GroupActive Control1 Intervention
Dream Group (n=21) will be subjected to an anesthetic protocol resulting in dream experiences during anesthesia.
Group II: No-Dream GroupPlacebo Group1 Intervention
No-Dream Group (n=21) will be subjected to an anesthetic protocol resulting in no dream experiences during anesthesia.
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Stanford UniversityStanford, CA
Loading ...
Who Is Running the Clinical Trial?
Stanford University
Lead Sponsor
Trials
2527
Patients Recruited
17,430,000+
Tiny Blue Dot Foundation
Collaborator
Trials
9
Patients Recruited
640+
Tiny Blue Dot Foundation
Collaborator
Trials
10
Patients Recruited
660+